1
Clinical Trials associated with TUL12101TUL12101滴眼液在健康成人受试者中单次和多次给药的安全性、耐受性和药代动力学特征的Ⅰ期临床试验
[Translation] Phase I clinical trial of the safety, tolerability and pharmacokinetic characteristics of single and multiple doses of TUL12101 eye drops in healthy adult subjects
主要目的:评估TUL12101滴眼液在健康成人受试者中单次和多次给药的安全性和耐受性。
次要目的:评估TUL12101滴眼液在健康成人受试者中单次和多次给药的血液药代动力学(PK)特征;评估TUL12101滴眼液在健康成人受试者中给药后的泪液药物浓度水平和PK特征;鉴定TUL12101滴眼液在健康成人受试者中的代谢产物。
[Translation] Primary objective: To evaluate the safety and tolerability of single and multiple administrations of TUL12101 eye drops in healthy adult subjects.
Secondary objectives: To evaluate the blood pharmacokinetic (PK) characteristics of single and multiple administrations of TUL12101 eye drops in healthy adult subjects; To evaluate the tear drug concentration level and PK characteristics of TUL12101 eye drops after administration in healthy adult subjects; To identify the metabolites of TUL12101 eye drops in healthy adult subjects.
100 Clinical Results associated with TUL12101
100 Translational Medicine associated with TUL12101
100 Patents (Medical) associated with TUL12101
100 Deals associated with TUL12101